SELE and peripheral arterial disease: A study of 157 patients with PAD and 206 in the control group that analyzed genetic polymorphism demonstrated that E-selectin was independently associated with PAD, and synergistic effects were identified, resulting in a genetic profile that significantly influences the increased risk of CLTI [60].